UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2193

2020

Volltextzugriff (PDF)

T-Cell Acute Lymphoblastic Leukemia—Current Concepts in Molecular Biology and Management

Biomedicines, 2021-11, Vol.9 (11), p.1621

2021

Volltextzugriff (PDF)

Management of post‐autologous transplant relapse in patients with T‐cell lymphomas

American journal of hematology, 2024-08, Vol.99 (8), p.1485-1491

2024

Volltextzugriff (PDF)

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Blood advances, 2021-01, Vol.5 (1), p.143-155

2021

Volltextzugriff (PDF)

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

The Lancet (British edition), 2024-07, Vol.404 (10450), p.353-363

2024

Volltextzugriff (PDF)

Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2664-2671

2021

Volltextzugriff (PDF)

Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma

Bone marrow transplantation (Basingstoke), 2021-02, Vol.56 (2), p.368-375

2021

Volltextzugriff (PDF)

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

Journal for immunotherapy of cancer, 2024-07, Vol.12 (7), p.e008975

2024

Volltextzugriff (PDF)

A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis

Haematologica (Roma), 2016-04, Vol.101 (4), p.417

2016

Volltextzugriff (PDF)

Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report

Journal of medical case reports, 2021-03, Vol.15 (1), p.170-170, Article 170

2021

Volltextzugriff (PDF)

Vulnerability of Gen-Z to E-Commerce Deception on Consumer's Belief Categories in Online Product Recommendations Systems

Kvalita inovácia prosperita, 2024-07, Vol.28 (2)

2024

Volltextzugriff (PDF)

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Nature medicine, 2021-08, Vol.27 (8), p.1419-1431

2021

Volltextzugriff (PDF)

Adoption of pediatric‐inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population‐based study

Cancer, 2017-01, Vol.123 (1), p.122-130

2017

Volltextzugriff (PDF)

Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2-Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System

Journal of clinical oncology, 2014-07, Vol.32 (20), p.2151-2158

2014

Volltextzugriff (PDF)

Ultra-Sensitive Next-Generation Sequencing Establishes the Prognostic Value of Very Low MRD in Adults with Acute Lymphoblastic Leukemia Undergoing Hematopoietic Cell Transplantation

Blood, 2022-11, Vol.140 (Supplement 1), p.1732-1733

2022

Volltextzugriff (PDF)

Outcomes for Myelofibrosis Patients Following Myeloablative Allogeneic Stem Cell Transplantation Using the Orca-T Graft from HLA-Matched Related and Unrelated Donors

Blood, 2021-11, Vol.138 (Supplement 1), p.1819-1819

2021

Volltextzugriff (PDF)

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.10318-10320

2022

Volltextzugriff (PDF)

Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.4788-4789

2022

Volltextzugriff (PDF)

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

Science translational medicine, 2021-10, Vol.13 (617), p.eabf5264

2021

Volltextzugriff (PDF)

Axicabtagene ciloleucel (axi-cel) in combination with rituximab (Rtx) for the treatment (Tx) of refractory large B-cell lymphoma (R-LBCL): Outcomes of the phase 2 ZUMA-14 study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7567-7567

2022

Volltextzugriff (PDF)

ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL)

Blood, 2020-11, Vol.136 (Supplement 1), p.6-7

2020

Volltextzugriff (PDF)

Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Blood, 2023-06, Vol.141 (22), p.2727-2737

2023

Volltextzugriff (PDF)

Advance Directive Utilization Decreases Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Blood, 2017-12, Vol.130, p.278-278

2017

Volltextzugriff (PDF)

Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Leukemia & lymphoma, 2017-03, Vol.58 (3), p.516-527

2017

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(96)

Sprache

Englisch
(96)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(21)
Hematology
(20)
Adult
(10)
Transplantation
(9)
Immunology
(8)
Oncology
(8)
Leukemia
(6)
Middle Aged
(6)
Patients
(6)
Acute Lymphoblastic Leukemia
(5)
Aged
(5)
Antigens
(5)
Hematopoietic Stem Cell Transplantation
(5)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(5)
Lymphocytes
(5)
Lymphocytes T
(5)
Male
(5)
Stem Cell Transplantation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia

T-Cell Acute Lymphoblastic Leukemia—Current Concepts in Molecular Biology and Management

Management of post‐autologous transplant relapse in patients with T‐cell lymphomas

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma

Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis

Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report

Vulnerability of Gen-Z to E-Commerce Deception on Consumer's Belief Categories in Online Product Recommendations Systems

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Adoption of pediatric‐inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population‐based study

Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2-Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System

Ultra-Sensitive Next-Generation Sequencing Establishes the Prognostic Value of Very Low MRD in Adults with Acute Lymphoblastic Leukemia Undergoing Hematopoietic Cell Transplantation

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

Outcomes for Myelofibrosis Patients Following Myeloablative Allogeneic Stem Cell Transplantation Using the Orca-T Graft from HLA-Matched Related and Unrelated Donors

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma

Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

Axicabtagene ciloleucel (axi-cel) in combination with rituximab (Rtx) for the treatment (Tx) of refractory large B-cell lymphoma (R-LBCL): Outcomes of the phase 2 ZUMA-14 study

ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL)

Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Advance Directive Utilization Decreases Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Suchergebnisse filtern